2005～2007年抗高血压药物使用情况分析  

Analysis of Utilization of the Antihypertensive from 2005 to 2007

作　　者：刘春霞[1] 杨鸿[1] 余晓霞[1] 陈杰[2] 

机构地区：[1]中山大学附属第二医院药学部,510120 [2]广东药学院

出　　处：《岭南急诊医学杂志》2008年第2期125-127,共3页Lingnan Journal of Emergency Medicine

摘　　要：目的:通过对中山大学附属第二医院(中山二院)2005年～2007年抗高血压药物使用情况的调查分析,评价近三年间抗高血压药的应用状况和用药的合理性。方法:回顾性分析中山二院2005年～2007年抗高血压药的年购药金额、用药频度(DDDs)及日用药金额(DDDC)等资料。结果:中山二院2005年～2007年抗高血压药的购药金额、DDDs及DDDC逐年增长,购药金额排在前三位的是钙通道阻滞剂、血管紧张素Ⅰ转换酶抑制剂(ACEI)和血管紧张素Ⅱ受体拮抗剂(ARB),其中钙通道阻滞剂三年都排在第一,2005年ACEI、ARB分列二三位,而2006和2007年ARB排第二,ACEI排第三。结论:中山二院抗高血压药的应用状况与我国抗高血压药总体用药状况基本相符。Objective： To evaluate the utilization and reasonable of antihypertensive agents used in the second affiliated hospital of Sun Yat-sen university from 2005 to 2007. Methods： The data of antihypertensive agents in the hospital from 2005 to 2007 were analyzed statistically in terms of drug varieties, consumption sum,defined daily dose （DDDs） and defined daffy dose cost （DDDC）. Results：The purchase of antihypertensive drugs amount of DDDs and DDDC were grown yearly in the hospital from 2005-2007, the amount of the purchase is the top three medicines including calcium channel blockers, ACEI and ARB, which calcium channel blocker was three years of stagnation in the first row, in 2005 ACEI and ARB points out second and third, but in 2006 and 2007 the ARB in the second row and the ACEI in the third row. Conclusion： Antihypertensive drug application status and development trend in the hospital is correspond of the general situation of antihypertensive drug in China.

关 键 词：抗高血压药 购药金额 用药频度 日用药金额 

分 类 号：R544.1[医药卫生—心血管疾病]